Protein-tRNA Agarose Gel Retardation Assays for the Analysis of the N6-threonylcarbamoyladenosine TcdA Function

Summary

A protocol is presented for the production of tRNA(UUU) and the analysis of tRNA(UUU) in complex with the enzyme TcdA by agarose gel retardation assays.

Abstract

We demonstrate methods for the expression and purification of tRNA(UUU) in Escherichia coli and the analysis by gel retardation assays of the binding of tRNA(UUU) to TcdA, an N⁶-threonylcarbamoyladenosine (t⁶A) dehydratase, which cyclizes the threonylcarbamoyl side chain attached to A37 in the anticodon stem loop (ASL) of tRNAs to cyclic t⁶A (ct⁶A). Transcription of the synthetic gene encoding tRNA(UUU) is induced in E. coli with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and the cells containing tRNA are harvested 24 h post-induction. The RNA fraction is purified using the acid phenol extraction method. Pure tRNA is obtained by a gel filtration chromatography that efficiently separates the small-sized tRNA molecules from larger intact or fragmented nucleic acids. To analyze TcdA binding to tRNA(UUU), TcdA is mixed with tRNA(UUU) and separated on a native agarose gel at 4 °C. The free tRNA(UUU) migrates faster, while the TcdA-tRNA(UUU) complexes undergo a mobility retardation that can be observed upon staining of the gel. We demonstrate that TcdA is a tRNA(UUU)-binding enzyme. This gel retardation assay can be used to study TcdA mutants and the effects of additives and other proteins on binding.

Introduction

The gel retardation assay¹ (also known as electrophoretic mobility shift assay, EMSA) is an electrophoretic method designed to study and characterize protein-nucleic acid interactions. It allows the analysis of protein-DNA as well as protein-RNA interactions and in particular, interactions between tRNA and tRNA-binding proteins, using either purified components or complex mixtures of proteins (e.g., cell lysates) or nucleic acids (e.g., tRNA pools). We have applied gel retardation assays to the study of the interaction between purified tRNA(UUU) and TcdA, an N⁶-threonylcarbamoyladenosine (t⁶A) dehydratase, which cyclizes the threonylcarbamoyl side chain attached to A37 in the anticodon stem loop (ASL) of tRNAs to cyclic t⁶ (ct⁶A)^2,3. TcdA is also known as CsdL^3,4. The tcdA/csdL gene forms a cluster with the csdA and csdE genes⁵, which encode the cysteine desulfurase and the sulfur acceptor of the cysteine sulfinase desulfinate (CSD) system and is required to sustain TcdA function in vivo³.

The rationale behind the gel retardation assays is that, while free nucleic acid molecules migrate rapidly to the front of acrylamide or agarose gels by virtue of their large negative charge, the electrophoretic mobility of protein complexes of the same nucleic acids is dramatically reduced. The reduction in mobility is visualized as a "shift" in the nucleic acid-protein complexes, which resolve as discrete bands. Positively charged and larger nucleic acid-protein complex show a greater shift or reduction in mobility on a gel.

Since charge neutralization of the complex is a universal phenomenon for protein-nucleic acid complexes, the gel retardation assay can be applied to a wide range of complexes and nucleic acid types. The method is simple, inexpensive, and can be conducted in laboratories with minimum equipment. It requires only small amounts of proteins and tRNA. This is an advantage over alternative biophysical techniques, which usually consume larger quantities of sample.

The gel retardation assay has been widely used for the study of transcription factors. The assay has been used to analyze binding kinetics, strength, and specificity of transcription factors for many different DNA sequences. It was indeed in this field that the EMSA was first developed^6,7. Gel retardation assays with RNA^8,9,10,11 and tRNA molecules have also been used in ribosome research and to analyze, as we do here, the enzymes that modify tRNA nucleosides post-transcriptionally.

Many different parameters affect the result of a gel retardation assay such as temperature, quality of the protein and tRNA sample, and the strength of the binding. Careful planning and execution of the experiment is crucial for the interpretation of the results of the free nucleic acid and protein-bound species. Here, we used the synthetic gene encoding tRNA(UUU) cloned into an expression vector whose promoter lacks the Shine-Dalgarno ribosome binding site, leading to the synthesis of large amounts of the tRNA². This detailed protocol is intended to provide a clear guide for performing tRNA gel retardation experiments while avoiding common mistakes.

Protocol

Caution: Consult all relevant material safety data sheets (MSDS) before use. Several of the chemicals used in this protocol are toxic and corrosive. Use appropriate practices when performing the extraction of tRNA using phenol, including the use of a fume hood and personal protective equipment (safety glasses, gloves, lab coat, full-length pants, closed-toe shoes, etc.). This protocol uses a non-toxic nucleic acid stain. The use of alternative stains may require additional precautions and specialized disposal of the staining agent if toxic and/or carcinogenic (e.g., ethidium bromide).

1. Preparation of the Agarose Gel

1. Weigh 2 g of agarose and add it to a glass bottle to prepare a 2% w/v agarose gel.
2. Add 100 mL of 1x tris-borate-ethylenediaminetetraacetic acid (EDTA) (TBE) running buffer to the agarose-containing bottle. Melt by heating in a microwave. At 30 s intervals, swirl the contents to mix well and repeat this step until the agarose is completely dissolved. Allow the agarose solution cool down to approximately 50-60 °C.
3. Tape the open edges of a gel tray to create a mold, place an appropriate comb to create the wells and cast the molten agarose into it. Avoid bubble formation and let it solidify at room temperature.
4. Once solidified, place the gel tray in an electrophoresis unit and fill it with TBE buffer until the gel is fully covered.

2. Preparation of the tRNA

1. Express tRNA(UUU) in E. coli
   1. In the morning, use a vial of frozen E. coli BL21(DE3) transformed with the expression vector pET23d-EcUUU² (harbors the gene encoding E. coli tRNA(UUU)), to streak a low-salt Luria Broth (LB) plate supplemented with 100 µg/mL ampicillin. Invert the plate and place it into a 37 °C incubator until colonies appear (late afternoon).
   2. Inoculate one well-grown, single colony in 5 mL LB plus 100 µg/mL ampicillin and grow overnight at 220 rpm at 37 °C.
   3. The next morning, pellet the cells (6,500 x g for 10 min at 4 °C), replace medium with 5 mL fresh LB plus 100 µg/mL ampicillin and resuspend. Use this suspension to inoculate 200 mL LB plus 100 µg/mL ampicillin. Grow for 5 h at 220 rpm at 37 °C.
   4. When the optical density of the culture at 590 nm (OD₅₉₀) has reached 0.6 - 0.8, add 1 mM IPTG to the culture to trigger the expression of the tRNA(UUU) gene. Incubate at 37 °C for 3 h.
   5. Harvest the cells by centrifuging the culture at 6,500 x g for 10 min at 4 °C.
2. Lysis and extraction
   1. Resuspend the cell pellet in 5 mL lysis buffer (0.3 M sodium acetate, 10 mM EDTA). From this point onward, used autoclaved buffers and keep all the tRNA-containing samples at 4 °C to prevent tRNA degradation.
   2. Add 1 volume of acid phenol (pH 4.3) to the resuspended cell pellet in the fume hood. Mix for 1 min by inversion to lyse the cells and centrifuge at 10,000 x g (10 min, 4 °C).
   3. Collect the upper aqueous phase containing the soluble tRNA(UUU) (and smaller concentrations of the other tRNA pools) using a pipette taking care not to aspirate the organic (bottom) phase. Discard the bottom layer and the pellet, which consists of the organic phase and cell debris, into an adequate container.
   4. Precipitate the tRNA by thoroughly mixing the soluble (aqueous) phase with 2.5 volume 100% v/v ethanol by inversion for 1 h at 4 °C. Centrifuge the mixture at 15,000 x g (30 min, 4 °C).
   5. Decant the supernatant carefully and resuspend the tRNA-rich pellet in 4 mL gel filtration buffer (20 mM sodium phosphate or potassium phosphate, pH 7.4, 0.1 mM EDTA). Run 5 µL of the resuspended tRNA pool on a 2% w/v agarose gel.
      NOTE: Good quality tRNA appears as a single band (molecular size between 50-100 bp).
3. Purification of tRNA(UUU)
   1. Following standard chromatographic practice¹², load the resuspended tRNA(UUU) onto a high-resolution preparative gel filtration column (dimensions: 16 x 600 mm, bed volume: 120 mL, resolution range: 1,000-70,000 Da) previously equilibrated in gel filtration buffer (mobile phase). Set the flow rate to 1 mL/min to elute the samples.
      NOTE: The tRNA(UUU) peak elutes approximately at 75.5 mL. Typically, a yield of 0.5-1.0 mg/L tRNA of culture can be obtained.
   2. Analyze the samples at representative elution volumes by electrophoresing 5 - 10 µL of each sample on a 2% w/v agarose gel.

3. Sample Preparation

1. Express and purify TcdA according to López-Estepa et al.².
   NOTE: Up to 250 µM TcdA can be used for the study.
2. Pipette the corresponding amount of TcdA as per Table 1 into properly labeled 1.5 mL centrifuge tubes. Add 1.6 mM tris(2-carboxyethyl)phosphine (TCEP) (final concentration) and gently mix using a pipette. Close the lid and incubate the mixture at room temperature for 5 min.
3. Add 10 µM of adenosine triphosphate (ATP) and 50 mM MgCl₂ (final concentrations). Mix with a pipette and incubate the mixture for 5 min at room temperature.
4. Add purified tRNA(UUU) (section 2.3) as per Table 1, mix with a pipette and incubate at room temperature for 5 min.
5. Add phosphate buffered saline (PBS) up to 100 µL final volume. Mix properly and add glycerol to a final concentration of 10% v/v.
6. Vortex the sample and briefly spin down the contents of the tube (10,000 x g, 1 min, 4 °C).

4. Gel Loading and Electrophoresis Development

1. Place electrophoresis unit into a tray filled with crushed ice to maintain the chamber at 4 °C during the electrophoresis run.
2. Carefully, pipette 5 µL of each sample into the corresponding well. Add a suitable DNA size marker.
3. Plug the electrodes into the corresponding slots of the power supply unit. Turn on the power supply unit and set the voltage to 100 V and run the gel for 90 min.

5. Gel Staining to Observe tRNA-Protein Interaction

1. Prepare the staining solution by mixing 50 mL of TBE with 1x of a suitable DNA stain. Avoid exposing the staining solution to sunlight by covering the staining container with aluminum foil.
   NOTE: DNA stains are usually stored as 10,000 or 20,000x concentrated stocks.
2. After 90 min of electrophoresis, carefully remove the gel from the tray and place it in a container with staining solution. Place it on a rocker at low rocking speed at room temperature for 30 min.
3. Remove the agarose gel from the staining container, tap it carefully on a piece of cellulose tissue or filter paper to remove excess liquid, and place it directly on a transilluminator. Switch on the UV light to visualize bands containing tRNA. Take a photograph of the gel.
4. Protein staining (optional).
   1. Discard the DNA staining solution safely (according to safety procedures) and substitute it with 50 mL Coomassie Brilliant Blue (CBB) solution. Place the tray on a rocker at room temperature and stain overnight (>12 h). Discard the CBB staining solution and replace it with 50 mL PBS to remove excess dye. Destain for 1 h on a rocker.
5. Visualize protein-containing tRNA complexes under a light transilluminator and take photographs of the gel to compare with the tRNA UV gel picture.

Results

Large amounts of tRNA(UUU) can be obtained by expressing the tRNA gene in E. coli under the control of a strong inducible T7 promoter. The expressed tRNA(UUU) accumulates in the cytoplasm and is enriched over the pool of naturally abundant tRNAs. A two-step purification process consisting of a capture/extraction step and a gel filtration/polishing step was utilized to obtain EMSA-grade tRNA. The capture/extraction step uses pH 4.3 phenol to achieve the simultaneous precipitation ...

Discussion

The protein-tRNA agarose gel retardation assay described herein can be modified in a number of ways. First, the percentage of agarose in the gel can be reduced to allow the separation and visualization of protein-tRNA complexes significantly larger than the one analyzed here (120 kDa). Second, if the target protein is thermolabile, extra precautions must be taken to ensure that the temperature is kept below the maximum acceptable temperature by moving the electrophoresis apparatus to a cold room or by using ice packs ins...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
E. coli BL21(DE3)	Novagen	70235	DE3 lysogen contains T7 polymerase upon IPTG induction.
pET23d	Novagen	69748-3	pET23d confers resistance to ampicillin; T7 promoter.
LB Broth, Low Salt (Lennox L Broth), Granulated	Melford	GL1703	Conventional LB Broth, High Salt, can also be used.
Ampicillin	Sigma-Aldrich	10419313
Incubator Shaker (Thermostated)	NBS	Excella E24	Any shaker incubator with temperature control can be used.
Isopropyl-beta-D-thiogalactopyranoside (IPTG), >=99%	Acros Organics	BP1755
Sodium acetate, anhydrous, >99%	Melford	B4017
Ethylenediaminetetraacetic acid (EDTA), Disodium salt, >99%	Acros Organics	AC327205000	Harmful if inhaled.
Centrifuge (refrigerated)	Eppendorf	5430
Centrifuge (refrigerated) rotor	Eppendorf	5430/5430P
Centrifuge	Sorvall	RC5C
Centrifuge rotor	Sorvall	SLA-3000
Phenol solution, Saturated with 0.1 M citrate buffer, pH 4.3 ± 0.2	Sigma-Aldrich	P4682	Acute toxicity (oral, dermal, inhalation), corrosive
Ethanol absolute for analysis, 100% v/v	Merck Millipore	100983
Sodium phosphate dibasic dihydrate, Na2HPO4, >=99%	Sigma-Aldrich	71643
Potassium dihydrogen phosphate, KH2PO4	Merck	48,730,250
HiLoad 16/60 Superdex 75	GE Healthcare	28989333
Agarose	Melford	MB1200
Tris [Tris(hydroxymethyl) aminomethane HCl]	Melford	T1513
Boric Acid	Melford	B0503
Microwave	Haier	HDA-2070M
TCEP [Tris(2-carboxyethyl)phosphine hydrochloride]	Sigma-Aldrich	C4706	Corrosive to metals and skin.
ATP [Adenosine 5′-triphosphate disodium salt hydrate], Grade I, >=99%	Sigma-Aldrich	A2383
Magnesium chloride (MgCl2), anhydrous, >=98%	Sigma-Aldrich	M8266
Sodium chloride (NaCl), >99%	Fisher Bioreagents	BP358
Potassium chloride (KCl), >99%	Melford	P0515
NZYDNA Ladder VI	NZYtech	MB8901
Power supply	Consort	EV261
Electrophoresis unit	Real Laboratory	RELSMINI10
Real Safe nucleic acid staining	Real Laboratory	RBMSAFE	20,000X stock
UV Transilluminator (G:Box/EF)	Syngene	2216498
Coomassie Brilliant Blue G	Sigma-Aldrich	B0770
Rocker (Gyro-Rocker)	Stuart	SSL3
Mixer Vortex	Fisher brand	13214789